SKU: VOMIVERT-20-40-10T
Vomivert Tablet is a prescription anti-vertigo medicine containing Cinnarizine 20 mg and Dimenhydrinate 40 mg. It helps manage vertigo symptoms, including spinning sensations, dizziness, nausea and vomiting associated with vestibular disorders.
Vomivert Tablet is an oral prescription medicine containing a combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg. It is primarily used for the symptomatic management of vertigo and balance-related problems, particularly when dizziness may be accompanied by nausea or vomiting. The combination works through complementary effects on the vestibular system and the nervous system to help reduce abnormal sensations of spinning, imbalance, and motion-related discomfort.
Vomivert Tablet is manufactured and marketed by Mankind Pharma Ltd. and is generally supplied as a strip of 10 tablets. The medicine should be taken only in the dose and duration recommended by a qualified healthcare professional. Because it may cause drowsiness or reduced alertness in some people, caution is advised with driving and activities that require concentration.
Vomivert Tablet is mainly used to manage symptoms associated with vertigo and vestibular balance disorders. Vertigo can create a sensation that the surroundings are moving or spinning even when the person is stationary. It may also be associated with nausea, vomiting, imbalance, or difficulty maintaining normal movement.
The combination of Cinnarizine and Dimenhydrinate may be prescribed for adults when treatment of vertigo symptoms is considered appropriate. The exact cause of dizziness should be evaluated by a healthcare professional because vertigo can have several different underlying causes.
Cinnarizine is a medicine with antihistamine and calcium-channel-blocking properties. It acts predominantly on the peripheral vestibular system and can help reduce excessive stimulation of the balance mechanisms in the inner ear. By reducing abnormal vestibular signals, Cinnarizine can help decrease sensations such as dizziness and spinning.
Dimenhydrinate is an antihistamine that acts on pathways involved in balance and nausea. It can reduce signals associated with motion sickness and vestibular disturbances and may help control nausea and vomiting accompanying dizziness.
Together, Cinnarizine and Dimenhydrinate provide complementary effects on the vestibular system and central nervous system. Clinical product information for this fixed-dose combination describes its use for the symptomatic treatment of vertigo in adults.
When prescribed for an appropriate condition, Vomivert Tablet may help control several uncomfortable symptoms associated with vestibular disturbances. Its benefits are related to symptom management rather than treating every possible underlying cause of vertigo.
Take Vomivert Tablet exactly as prescribed by your doctor. Swallow the tablet whole with water. Do not crush, chew, or break the tablet unless your healthcare professional specifically instructs you to do so.
It is generally recommended to take this medicine with or after food if advised by your doctor, particularly if you experience stomach discomfort. Try to take the medicine at the prescribed time and do not change the dose on your own.
The appropriate dosage depends on the patient's age, medical condition, symptoms, response to treatment, and other medicines being taken. Do not use a higher dose simply because dizziness has not improved immediately.
The dosage and duration of Vomivert Tablet should be decided by a healthcare professional. Product information for Cinnarizine/Dimenhydrinate 20 mg/40 mg tablets commonly describes adult dosing as one tablet three times daily, but the appropriate regimen for an individual patient can vary.
Do not use this information as a substitute for your doctor's prescription. The medicine should not be taken more frequently or for a longer period than recommended.
Like other medicines, Vomivert Tablet may cause side effects in some people. Many side effects are mild and may improve as the body adjusts to treatment, but persistent or severe symptoms should be discussed with a healthcare professional.
Dimenhydrinate can cause drowsiness, dry mouth, headache and coordination problems. Avoid driving or operating machinery until you understand how the medicine affects you.
Vomivert Tablet may cause drowsiness or reduced alertness. Avoid driving, cycling, operating machinery, or performing activities requiring concentration until you know how the medicine affects you.
Alcohol may increase the sedative effects of Dimenhydrinate and can make drowsiness or impaired alertness worse. It is advisable to avoid alcohol while taking this medicine.
If you are pregnant, planning pregnancy, or breastfeeding, speak with your doctor before taking Vomivert Tablet. Your healthcare professional can determine whether the potential benefits outweigh any possible risks.
Older adults may be more sensitive to the sedating and anticholinergic effects of Dimenhydrinate. Medical supervision is particularly important when this medicine is used in elderly patients.
Tell your doctor if you have glaucoma, asthma or other breathing problems, difficulty urinating, prostate-related problems, seizures, liver or kidney disease, or other chronic medical conditions before starting treatment.
Tell your doctor about all prescription medicines, over-the-counter products, vitamins, supplements, and herbal products you are taking. Medicines that cause drowsiness may increase the sedative effects of Dimenhydrinate.
Special caution may be required when Vomivert Tablet is combined with other antihistamines, sedatives, sleep medicines, certain psychiatric medicines, or alcohol. Your doctor or pharmacist can review your current medicines and identify potentially important interactions.
If you miss a scheduled dose, take it when you remember unless it is almost time for the next dose. If the next dose is due soon, skip the missed dose and continue with the regular schedule. Do not take two doses together to compensate for a missed dose.
Current medicine listings report storage below 30°C for Vomivert 20mg/40mg Tablet.
Vomivert Tablet is intended for symptomatic management and should not be used to self-diagnose unexplained dizziness. Vertigo can sometimes be related to conditions requiring medical evaluation. Seek prompt medical attention if dizziness is accompanied by severe headache, weakness, difficulty speaking, chest pain, fainting, vision changes, seizures, or other concerning symptoms.
Do not increase the dose or continue treatment for an extended period without medical advice. If symptoms continue, become more frequent, or worsen despite treatment, consult your doctor for further evaluation.
Vertigo is different from ordinary light-headedness because it often involves a false sensation of movement or spinning. It may arise from problems affecting the inner ear or other parts of the balance system. Medicines such as Dimenhydrinate may be used to help manage dizziness in selected situations, while treatment of the underlying cause remains important.
Vomivert combines Cinnarizine and Dimenhydrinate, providing both peripheral and central effects on vestibular pathways. The fixed-dose combination is indicated for symptomatic treatment of vertigo in adults in approved product information.
Vomivert Tablet is primarily used for the symptomatic management of vertigo and associated symptoms such as dizziness, spinning sensations, nausea, and vomiting.
Each tablet contains Cinnarizine 20 mg and Dimenhydrinate 40 mg.
Yes. Dimenhydrinate may cause drowsiness or reduced alertness. Avoid driving or operating machinery until you know how the medicine affects you.
It is advisable to avoid alcohol because alcohol may increase drowsiness and other central nervous system effects associated with Dimenhydrinate.
Yes. Current pharmacy listings identify Vomivert Tablet as a prescription medicine. It should be used according to the advice of a qualified healthcare professional.
Current listings recommend storing Vomivert Tablet below 30°C and protecting it from excessive heat and moisture.
For additional information about medicines used for balance and dizziness, patients can explore the BuyCenforce Neurology & Vertigo Care Category and related health information through the BuyCenforce Health Blog.
Patients looking for medicines in other therapeutic categories can also explore the BuyCenforce Respiratory Care Category.
For reliable medicine information, visit MedlinePlus – Dimenhydrinate, the Therapeutic Goods Administration – Cinnarizine/Dimenhydrinate, and the Australian Prescriber – Cinnarizine/Dimenhydrinate for Vertigo.
This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medicine.
| Brand | Mankind Pharma |
| Manufacturer | |
| Composition | |
| Package | |
| Ship time |
Free Shipping
For all oders over $99
Secure Payment
100% secure payment
24/7 Support
Online top support